IRIS Accounts Production v23.1.5.20 13345642 director 1.5.22 31.3.23 31.3.23 0 0 true false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure133456422022-04-30133456422023-03-31133456422022-05-012023-03-31133456422021-04-18133456422021-04-192022-04-30133456422022-04-3013345642ns16:EnglandWales2022-05-012023-03-3113345642ns15:PoundSterling2022-05-012023-03-3113345642ns11:Director12022-05-012023-03-3113345642ns11:PrivateLimitedCompanyLtd2022-05-012023-03-3113345642ns11:SmallEntities2022-05-012023-03-3113345642ns11:AuditExempt-NoAccountantsReport2022-05-012023-03-3113345642ns11:SmallCompaniesRegimeForDirectorsReport2022-05-012023-03-3113345642ns11:SmallCompaniesRegimeForAccounts2022-05-012023-03-3113345642ns11:FullAccounts2022-05-012023-03-311334564212022-05-012023-03-3113345642ns11:OrdinaryShareClass12022-05-012023-03-3113345642ns11:RegisteredOffice2022-05-012023-03-3113345642ns6:CurrentFinancialInstruments2023-03-3113345642ns6:CurrentFinancialInstruments2022-04-3013345642ns6:Non-currentFinancialInstruments2023-03-3113345642ns6:Non-currentFinancialInstruments2022-04-3013345642ns6:ShareCapital2023-03-3113345642ns6:ShareCapital2022-04-3013345642ns6:RetainedEarningsAccumulatedLosses2023-03-3113345642ns6:RetainedEarningsAccumulatedLosses2022-04-3013345642ns6:NetGoodwill2022-05-012023-03-3113345642ns6:IntangibleAssetsOtherThanGoodwill2022-05-012023-03-3113345642ns6:NetGoodwill2022-04-3013345642ns6:NetGoodwill2023-03-3113345642ns6:NetGoodwill2022-04-3013345642ns6:CostValuation2022-04-3013345642ns6:Subsidiary12022-05-012023-03-31133456421ns6:Subsidiary12022-05-012023-03-3113345642ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3113345642ns6:WithinOneYearns6:CurrentFinancialInstruments2022-04-3013345642ns11:OrdinaryShareClass12023-03-3113345642ns6:RetainedEarningsAccumulatedLosses2022-04-3013345642ns6:RetainedEarningsAccumulatedLosses2022-05-012023-03-31
REGISTERED NUMBER: 13345642 (England and Wales)















Unaudited Financial Statements

for the Period 1 May 2022 to 31 March 2023

for

Datco Healthcare Ltd

Datco Healthcare Ltd (Registered number: 13345642)






Contents of the Financial Statements
for the Period 1 May 2022 to 31 March 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Datco Healthcare Ltd

Company Information
for the Period 1 May 2022 to 31 March 2023







DIRECTOR: Mrs S Gangji





REGISTERED OFFICE: 20 Tadworth Parade
Hornchurch
RM12 5AS





REGISTERED NUMBER: 13345642 (England and Wales)





ACCOUNTANTS: HSY Accountants Ltd
Chartered Certified Accountants &
Statutory Auditors
20 Tadworth Parade
Elm Park
RM12 5AS

Datco Healthcare Ltd (Registered number: 13345642)

Statement of Financial Position
31 March 2023

31.3.23 30.4.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 48,295 48,295
Investments 5 1,577,603 1,577,603
1,625,898 1,625,898

CURRENT ASSETS
Debtors 6 91,794 20,520
Cash at bank 95,508 230,960
187,302 251,480
CREDITORS
Amounts falling due within one year 7 1,064,629 1,077,011
NET CURRENT LIABILITIES (877,327 ) (825,531 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

748,571

800,367

CREDITORS
Amounts falling due after more than
one year

8

784,089

833,008
NET LIABILITIES (35,518 ) (32,641 )

CAPITAL AND RESERVES
Called up share capital 9 1,000 1,000
Retained earnings 10 (36,518 ) (33,641 )
SHAREHOLDERS' FUNDS (35,518 ) (32,641 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Datco Healthcare Ltd (Registered number: 13345642)

Statement of Financial Position - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 26 December 2023 and were signed by:





Mrs S Gangji - Director


Datco Healthcare Ltd (Registered number: 13345642)

Notes to the Financial Statements
for the Period 1 May 2022 to 31 March 2023

1. STATUTORY INFORMATION

Datco Healthcare Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Goodwill
Goodwill being the amount paid in connection with the acquisition of business in the year. No amortisation is provided in the year.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2022 - NIL).

Datco Healthcare Ltd (Registered number: 13345642)

Notes to the Financial Statements - continued
for the Period 1 May 2022 to 31 March 2023

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 May 2022
and 31 March 2023 48,295
NET BOOK VALUE
At 31 March 2023 48,295
At 30 April 2022 48,295

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 May 2022
and 31 March 2023 1,577,603
NET BOOK VALUE
At 31 March 2023 1,577,603
At 30 April 2022 1,577,603

The company's investments at the Statement of Financial Position date in the share capital of companies include the following:

Theydon Bois Pharmacy Limited
Registered office: 20 Tadworth Parade, Elm Park RM12 5AS
Nature of business: Dispensing Chemist
%
Class of shares: holding
Ordinary 100.00

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 30.4.22
£    £   
Other debtors 91,794 20,520

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 30.4.22
£    £   
Bank loans and overdrafts 97,356 88,472
Other creditors 967,273 988,539
1,064,629 1,077,011

Datco Healthcare Ltd (Registered number: 13345642)

Notes to the Financial Statements - continued
for the Period 1 May 2022 to 31 March 2023

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN
ONE YEAR
31.3.23 30.4.22
£    £   
Bank loans 784,089 833,008

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal 784,089 833,008

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.23 30.4.22
value: £    £   
1,000 Ordinary 1 1,000 1,000

10. RESERVES
Retained
earnings
£   

At 1 May 2022 (33,641 )
Deficit for the period (2,877 )
At 31 March 2023 (36,518 )

11. ULTIMATE CONTROLLING PARTY

Shaheen Gangji and Siraj Muhammad who are shareholders control the company by virtue of their shareholding.